Lynn Kirkpatrick's Net Worth

$446 Thousand

Estimate Recalculated Feb 7, 2024 03:52PM EST

Who is Lynn Kirkpatrick?

Lynn Kirkpatrick does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Oncothyreon Inc., and Ensysce Biosciences, Inc..

SEC CIK

Lynn Kirkpatrick's CIK is 0001418785

Past Insider Trading and Trends

2021 was Lynn Kirkpatrick's most active year for acquiring shares with 8 total transactions. Lynn Kirkpatrick's most active month to acquire stocks was the month of May. 2022 saw Lynn Kirkpatrick paying a total of $48,298.50 for 497,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Oncothyreon Inc. No price found

Chief Scientific Officer

Lynn Kirkpatrick owns 1,613,872 units of Common Stock. In the year 2007 Lynn Kirkpatrick acquired a total of 1,613,872 shares in Oncothyreon Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 4
Form 4
∞
1.61M
—
—
1.61M
Dec 10
Form 3
—
0
—
—
0
No matching records found

Ensysce Biosciences, Inc. (ENSC) Snapshot price: $1.295

Chief Executive Officer

Lynn Kirkpatrick owns 381,851 units of Common Stock which is worth $494,497.05. In the year 2021 Lynn Kirkpatrick acquired a total of 381,851 shares in Ensysce Biosciences, Inc. at a cost of $48,298.50.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+34.05%
97K
$0.50
$48,298.50
381.85K
Feb 17 - May 26
Form 4
—
0
—
—
0
Feb 17
Form 4
∞
284.85K
—
—
284.85K
Jun 30
Form 3
—
0
—
—
0
No matching records found